Company intelligence / Profile preview

AxioBionics

Ann Arbor, Michigan, United States

Ownership: Private
Development stage: Other

Overview

AxioBionics' devices, including Wearable Therapy and TripleFlex, have demonstrated clinically significant improvements in muscle function, activity, and quality of life for patients with chronic pain, paralysis, and other neuromuscular disabilities. Published studies, including a 10-year arm mobility study, show sustained and consistent improvement in functional outcomes for patients with neurological impairments.

Therapeutic areas: NeurologyCardiovascular
Modalities: DeviceNon-pharmacological therapyWearable electrical stimulation system
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on AxioBionics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AxioBionics.

Explore the full profile